Letter from Japan
- 23 April 2024
- journal article
- letter
- Published by Wiley in Respirology
- Vol. 29 (7) , 637-639
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of the 23-valent pneumococcal polysaccharide vaccine on the incidence of hospitalization with pneumonia in adults aged ≥65 years: retrospective cohort study using a population-based database in JapanClinical Microbiology and Infection, 2023
- Mortality changes for patients with pneumococcal pneumonia from 2012 to 2017 in JapanJournal of Infection and Chemotherapy, 2022
- Dynamic changes in clinical characteristics and serotype distribution of invasive pneumococcal disease among adults in Japan after introduction of the pediatric 13-valent pneumococcal conjugate vaccine in 2013–2019Vaccine, 2022
- Pneumococcal meningitis in adults in 2014–2018 after introduction of pediatric 13-valent pneumococcal conjugate vaccine in JapanScientific Reports, 2022
- Reemergence of Invasive Pneumococcal Disease in Germany During the Spring and Summer of 2021Clinical Infectious Diseases, 2022
- Distribution and Variation of Serotypes and Pneumococcal Surface Protein A Clades of Streptococcus pneumoniae Strains Isolated From Adult Patients With Invasive Pneumococcal Disease in JapanFrontiers in Cellular and Infection Microbiology, 2021
- Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE)Vaccine, 2019
- Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, JapanPLOS ONE, 2019
- Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design studyThe Lancet Infectious Diseases, 2017